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The availability of an antigen-induced, antigen-specific system to measure in vitro 
antibody responses by human  B  cells  is  critical  for the  precise delineation  of the 
physiology of human  B  cell  activation  and  immunoregulation.  Specific  antibody 
production has been studied in man for several years. However, in doing so, some of 
the systems that have been employed have required induction by polyclonal B cell 
activators, whereas others, which have utilized direct stimulation  by antigen,  have 
been technically difficult to perform or unpredictable in terms of individual responses 
(1-3). 
We have previously reported (4)  that  the unfractionated peripheral blood mono- 
nuclear cells from normal human subjects immunized to the soluble protein antigen 
keyhole limpet hemocyanin (KLH)  1 could be induced in vitro by antigen alone or by 
pokeweed mitogen  (PWM)  to produce specific antibody.  In each case, the specific 
antibody production was  nonetheless associated with  polyclonal activation.  In  the 
present  study,  we  have  characterized  the  overlap between  antigen  specificity and 
polyclonality in the induction and expression of antigen-induced antibody production 
and  have  demonstrated  a  dichotomy between  antigen-specific and  polyclonal  re- 
sponses to two distinct protein antigens, KLH and tetanus toxoid (TT). In addition, 
we have precisely defined the culture conditions and cellular requirements for antigen- 
induced, antigen-specific antibody production by human peripheral blood B cells. 
Materials and Methods 
Immunizations.  Normal subjects, aged  18-40 yr, received two subcutaneous injections  of 5 
mg KLH (Calbiochem-Behring Corp., American Hoechst Corp., La Jolla, Calif.), which had 
been dialyzed against phosphate-buffered saline (PBS) and passed through a 0.45-/~m millipore 
filter. Injections were spaced by 2 wk. TT (Wyeth Laboratories, Marietta, Pa.), 5 If, was also 
administered subcutaneously to some subjects.  Immunizations were carried out under peer- 
reviewed National Institutes of Health protocols. 
Cell Separations.  Peripheral blood mononuclear cells were obtained from Hypaque-Ficoll 
gradients  in  a  standard  fashion  (5). These unfractionated mononuclear cells were  10-30% 
monocytes,  70-90% lymphoeytes, and 0-5% basophils  and granulocytes by morphology and 
x Abbreviations used in  this paper." KLH, keyhole limpet hemocyanin; PBS, phosphate-buffered  saline; 
PWM, pokeweed  mitogen; TT, tetanus toxoid. 
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nonspecific esterase  staining. Within the lymphocyte population there were 5-10% B cells as 
determined by surface immunoglobulin (Ig)  staining, using a  fluorescein-eonjugated F(ab')z 
fragment goat anti-human Ig (N. L. Cappel Laboratories Inc., Cochranville, Pa.) (6). 
T  cell-enriched populations were obtained from nylon wool columns (7). Cells eluted from 
the column were <1% surface Ig positive. T cell depletion was accomplished through the use of 
the anti-T cell  hybridoma antibody Leu-1  (Becton, Dickinson & Co.,  Oxnard, Calif.)  and 
rabbit serum (Dutchland Laboratories Inc., Dutchland Laboratory Animals Inc., Denver, Pa.) 
(8). Cells were suspended at a concentration of 107/ml in RPMI 1640 (Flow Laboratories, Inc., 
Rockville, Md.).  1/~g of antibody was added per 5 ×  106 cells, and the resulting mixture was 
combined with pooled, young rabbit serum, which had been screened for eytotoxicity, to yield 
a final concentration of rabbit serum of 20-30%.  The mixture was incubated for  1 h at 37°C 
and  the  cells  washed  three  times  in  RPMI  1640. Approximately 20%  of the  initial ceils 
remained. These cells were 90-95% viable by trypan blue dye exclusion, 15-40% B cells, 5-10% 
sheep erythrocyte rosette positive, and 30-50% monocytes by nonspecific esterase  staining and 
morphology. 
Monocyte depletion was performed by plate adherence of 40 ×  106 unfractionated cells in 2 
ml RPMI 1640 containing 1% human A serum for 1 h at 37°C in 100-mm petri dishes (9). The 
nonadherent cells  were  then  passed  through  Sephadex  G-10  (Pharmacia  Fine Chemicals, 
Piscataway, N. J.)  (10). Approximately 50% of the initial unfractionated cells remained after 
these two procedures, and these were <3% monocytes. Monocytes were obtained from contin- 
uous density gradients of Percoll (Pharmacia Fine Chemicals) (11) and then treated with 3,000 
rad. The purity of the monoeyte suspensions was 70-90%. 
Culture Conditions.  Cultures for the measurement of supernate Ig production were performed 
in 1 ml of RPMI  1640 containing 10% fetal calf serum (Grand Island Biological Co., Grand 
Island, N.Y.) in either 12- ×  75-ram round-bottomed test tubes or 24-well flat-bottomed plates 
with  16-mm wells  (Costar Data Packaging, Cambridge, Mass.),  as indicated. These cultures 
contained various amounts of KLH, PBS-dialyzed TT (Lederle,  Pearl River, N.Y.),  or PWM 
(Grand Island Biological Co.). KLH and "IT were diluted in RPMI 1640 containing I0% fetal 
calf serum. Cultures were incubated in a 5% CO2 atmosphere at 37°C and rocked at 4 cycle/ 
min. Cultures containing TT were washed free of antigen at day 4 of culture. Cell density in 
culture was varied as indicated depending on the experiment. Cultures were harvested at day 
12 unless otherwise indicated, and supernates were decanted and stored at 4°C until assay, 
usually within 1 wk. 
Cultures for measuring blast transformation were performed as previously described in 96- 
well microtiter dishes (Limbro Chemical Co., Hamden, Conn.) with  1 ×  105 cells/well (12). 
Cultures contained 0.2 ml RPMI  1640 with 15% human A serum. Various amounts of KLH 
diluted in 15% human A serum or PWM were added to cultures that were then incubated in 
a 5% COz atmosphere at 37°C for 5 d. 
Assays.  Specific and total Ig production were measured using enzyme-linked immunosor- 
bent assays  as has been previously reported  (4,  13). Flat-bottomed, 96-well  microtiter plates 
(Dynatech Laboratories Inc., Dynatech Corp., Alexandria, Va.) were first coated with 0.2 ml 
of a carbonate buffer, pH 9.6, containing  one of the following proteins: 1 p.g/ml KLH, 1 lf/ml 
TT  (Wyeth),  10 #g/ml  Fab  fragment  goat  anti-human IgG  (Fab fragment; N.  L.  Cappel 
Laboratories Inc.), or 10 ~g/ml IgG fraction goat anti-human IgM (heavy-chain specific; N. L. 
Cappel Laboratories Inc.) and allowed to incubate overnight at 4°C. Plates were then washed 
three  times  with  PBS  containing 0.05%  Tween  20  (Sigma Chemical Co.,  St.  Louis,  Mo). 
Samples were  appropriately diluted, added  to  duplicate wells  in a  volume of 0.2  ml, and 
incubated at room temperature for 2 h. The plates were then washed as before,  and 0.2 ml of 
a  1:1,000 dilution of heavy-chain-specific goat anti-human IgG or IgM conjugated to alkaline 
phosphatase  (Sigma  Chemical  Co.)  was  added  to  each  well.  The  plates  were  incubated 
overnight at 4°C, washed again, and then allowed to react with 0.2 ml per well of a  1 mg/ml 
solution of p-nitrophenyl phosphate  (Sigma Chemical  Co.)  in a  pH  8.6  carbonate buffer 
containing 0.001  M  MgC12. The  subsequent  development  of color  because  of enzymatic 
conversion of p-nitrophenyl phosphate to p-nitrophenol was measured using a  muhichannel 
spectrophotometer (Flow Laboratories, Inc.) and related to that seen with a standard serum 
containing a  known amount of anti-TT antibody expressed  in AU per ml, a  pool  of human H.  C.  LANE,  D. J.  VOLKMAN, G.  WHALEN,  AND  A.  S.  FAUCI  1045 
sera with a  known amount of IgG or IgM (N. L. Cappel Laboratories Inc.), or a  standard sera 
rich in either anti-KLH IgM or IgG. One DTM unit was defined as the amount of KLH-specific 
IgM present in a  1  : 10,000 dilution, and one DTG was defined as the amount of KLH-specific 
IgG present in a  1:100,000 dilution of the appropriate reference serum. 
Blast transformation was measured in cultures set up as outlined above. Cultures were pulsed 
with 2 #Ci of [ZH]thymidine on day 5 and harvested 4 h later on a Titertek cell harvester (Flow 
Laboratories,  Inc.).  The  filter  disks  were  placed  in  scintillation  vials  with  3  ml  Aquasol 
scintillation fluid (New England Nuclear, Boston, Mass.) and counted in a scintillation counter 
(model LS-350, Beckman Instruments, Fullerton, Calif). 
Results 
In Vitro  Induction of KLH-specific IgM Antibody Responses.  KLH-specific IgM antibody 
production was triggered by concentrations of KLH as low as 1 ng/ml in immunized 
subjects  (Fig.  1).  Peak responses were seen at concentrations of 50-200 ng KLH/ml. 
The levels of in vitro specific antibody production began to decline at in vitro antigen 
concentrations in the range of 1/xg/ml and were totally suppressed at concentrations 
of 20 #g/ml. This has been a  consistent finding in all 20 subjects studied.  Of note is 
the  fact  that  none of the  nonimmunized  subjects  studied  have been  able to  make 
specific antibody in response to in vitro KLH (Fig.  1). 
Similar curves were generated when the cells were washed free of antigen at day 4 
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FIG.  I.  In vitro induction of KLH-specific  IgM antibody responses as a function of in vitro antigen 
concentration. The responses of three individual immunized subjects and of a  pool of six nonim- 
munized subjects are shown. Cultures were performed in fiat-bottomed vessels with 1.5 ×  10  n cells 
per 1 ml culture. Data are expressed as geometric means +X SEM for triplicate cultures. 1046  IN VITRO ANTIGEN-SPECIFIC ANTIBODY  PRODUCTION  IN  MAN 
TABLE  I 
In  Vitro Anti-KLH-specific Antibody  Production * 
Subject 
Round-bottomed culture vessels:~  Flat-bottomed culture vessels§ 
Control  Antigen alonell  PWM alone  Control  Antigen alone  PWM alone 
1  1  12  1 
2  6  358  302 
3  3  56  160 
4  1  16  200 
5  1  14  2 
6  1  7  6 
7  4  210  141 
8  1  1  1 
9  4  100  6 
10  1  75  58 
11  2 +X 2.3'  72 +X 1.5  42 X 1.5 
12  48+  X 1.2  1983+  X 1.2  1277~  1.1 
13  15+X 1.1  126+X 1.5  ll+X 2.4 
14  16+  x  1.5  18+  x  1.4  51+  x  1.1 
15  1  282+  x  1.2  65+  x  1.1 
16  1+  x  1.1  49+  x  1.3  110+  x  1.1 
17  1  3+X2.5  50X 2.0 
18  3+  X 1.3  123+  x  1.1  54+  x  2.4 
i9  11 +X 3.4  39 +X 1.9  50 +X 2.0 
20  1  120 +X 1.2  32 +X 1.5 
Average  3 +X 1.3  48 +X 1.5  34 +X 1.5 
(1-2o) 
Average  2 +X 1.6  38 +X 1.9  54 +X 1.2 
(16-20) 7 
2 x  1.5  to9+  ~  1.1  1 +x  1.1 
1 +x 1.2  15 +x  1.1  i 
9+  x  1.1  72+  x  1.5  79+  x  1.1 
1  6 ×+ 1.4  4+  x  1.5 
l  11X  3.3  1 
2+Xl.5  24+X 1.7  3+X2.3 
* Data are expressed as DTM U/ml. 
:~ 5 ×  105 cells in 1 ml. 
§ 1.5 ×  106 cells in 1 ml. 
II 200 ng KLH. 
Geometric mean +X SEM for triplicate cultures. 
Cultures of subjects  16-20 were simultaneously performed in round-bottomed and flat-bottomed vessels, 
and the responses under both conditions were compared. 
and recultured in fresh media (4). This eliminated the possibility of a  significant assay 
artifact  related to the antigen  in culture. 
The  peak  in  vitro  KLH-specific,  IgM  antibody  responses  of the  unfractionated 
mononuclear  cells  from  20  consecutive  subjects  immunized  to  KLH  are  listed  in 
Table  I.  All but  two  subjects  (8  and  14)  showed  at  least  a  sixfold rise in specific in 
vitro  antibody  production  in  response  to  KLH.  The  average  increase  was  16-fold. 
One  subject  who  failed to respond  (subject  8)  was  experiencing a  viral syndrome  at 
the time of the study. 
PWM  was also capable of triggering antigen-specific antibody production  as a  part 
of the  total  polyclonal  response  induced  by  the  mitogen.  In  this  regard,  antigen- 
induced  and  PWM-induced  antigen-specific  responses  were  usually  comparable  in 
magnitude  in the cultures  performed  in the round-bottomed  vessels.  However, some 
subjects  (1,  9,  and  13)  manifested  a  much  greater  anti-KLH  response  to  antigenic H.  C.  LANE, D. J.  VOLKMAN, G.  WHALEN,  AND A.  S.  FAUCI  1047 
stimulation  than  to PWM  stimulation,  whereas other subjects  (4 and  17)  responded 
better to PWM. It is of particular importance to point out that the magnitude of the 
PWM-induced  specific  antibody  response  was  strictly  dependent  upon  the  culture 
conditions.  In four out of the five subjects whose lymphocytes were cultured  in flat- 
bottomed  as well  as round-bottomed  vessels,  at  high and  low cell  densities,  PWM- 
induced  specific  antibody  synthesis  was  apparent  only in  the  cultures  done  in  the 
round-bottomed vessels at the lower cell number. This phenomenon will be discussed 
in detail in a  later section. 
In  Vivo Kinetics of Antigen-specific Antibody Production.  Maximum  in  vitro  antigen- 
inducible,  antigen-specific IgM antibody responses were obtained  2 wk after booster 
immunization (Fig. 2). This same pattern of appearance of responsiveness was seen in 
all five subjects studied in this manner. However, the duration of the expression of in 
vitro  responsiveness  to  antigenic  stimulation  was  highly  variable.  Unfractionated 
mononuclear cells  from some subjects  became unresponsive  to antigen  as early as 4 
wk after booster immunization,  whereas  the cells from others could be triggered  by 
antigen  to  produce  specific  IgM  antibody  responses  up  to  1.5  yr  after  booster 
immunization.  Thus,  the  kinetics  of the  in  vivo  induction  of cells  that  could  be 
triggered in vitro was consistent  from subject to subject, whereas the duration  in the 
peripheral circulation of this antigen-responsive population of cells was quite variable. 
In contrast to the consistency seen in the development of antigen-induced antigen- 
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F]o.  2.  In vlvo kinetics of in vitro antigen-induced antibody synthesis. Cells were obtained from 
a  KLH-immune  individual  at  the  times indicated  and stimulated  in  vitro with  200 ng KLH. 
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FIC,  3.  Serum anti-KLH antibody levels as a function of time after immunization. Blood samples 
from six subjects were obtained at the intervals indicated and assayed for IgG and IgM antibodies 
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FIe.  5.  In vitro kinetics Of antigen-induced, antigen-specific antibody production for three indi- 
vidual  subjects. Triplicate  cultures performed in flat-bottomed vessels  with  1.5  ×  108 cells/1  ml 
culture and 200 ng KLH were harvested on the days shown. Data are expressed as geometric means 
+X SEM for the triplicate cultures. 
specific  IgM  responses,  the  antigen-specific  IgG  responses  were  highly  variable. 
Unfractionated mononuclear cells of some subjects produced specific IgG antibody as 
early as 1 wk after booster immunization whereas the cells of others were unable to be H.  C.  LANE,  D.  J.  VOLKMAN,  G.  WHALEN,  AND  A.  S.  FAUCI  1049 
triggered by antigen to produce specific IgG antibody as late as  1 yr after booster 
immunization. This occurred despite the persistent ability of those cells to produce 
specific IgM in response to antigen and the presence of substantial amounts of specific 
IgG antibody in the serum (Fig. 3). 
The  PWM-triggered  anti-KLH antibody responses  obtained several weeks after 
booster immunization were predominantly of the IgM isotype (Fig. 4), despite the 
simultaneous presence  of high  levels of KLH-specific IgG and  IgM  antibodies  in 
serum  (Fig.  3).  In  contrast,  the  unfractionated  mononuclear  cells  of these  same 
individuals,  triggered  1 yr later  by  PWM  produced  in  vitro  anti-KLH antibody 
responses primarily of the IgG isotype (Fig. 4). 
In  Vitro Kinetics.  Specific antibody production was first detected at day 4 or 5 of 
culture, with levels increasing to  a  maximum by day  10  (Fig.  5).  The  kinetics of 
specific anti-KLH IgG, total IgM, and total IgG production were identical with those 
of specific  anti-KLH IgM  production.  Of note is  the  fact that  antibody was  not 
detected in  any of the culture supernates collected from days 0  through  3.  Thus, 
antibody production was de novo, and it was necessary to incubate cultures for at 
least  10 d  in order to obtain maximal responses.  Prior irradiation of the cells with 
5,000 tad before culture completely eliminated in vitro antibody production, confirm- 
ing the de novo nature of the response (4). 
Relationship  between Specific and Polyclonal Responses.  Cell density was a major factor 
influencing the magnitude of the in vitro specific antibody response to antigen alone 
or the polyclonal B cell activator PWM. In flat-bottomed vessels, PWM induction of 
specific antibody production was maximum at a  cell density of 5  X  10  6 cells/well, 
whereas  antigen-induced specific antibody production was optimum at  1.5  X  10  6 
cells/well (Fig. 6). Of note is the fact that PWM-induced specific antibody synthesis 
was markedly reduced at the cell density yielding the maximal specific response to 
antigen. The converse was also true, that is, antigen-induced specific responses were 
diminished at the cell density that yielded the maximal PWM response. 
The geometry of the culture vessel was critical in determining the specificity of the 
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FIG.  6.  Role of cell  density in  influencing the magnitude of PWM  or antigen-induced specific 
antibody production. Triplicate cultures were performed on the unfractionated mononuclear cells 
from three subjects in flat-bottomed vessels at various cell densities and stimulated with either 200 
ng KLH (0) or a  1:200 dilution of PWM (O) stock solution. The geometric means of the individual 
responses were normalized to percent maximal responses; the data from the three subjects were then 
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antibody. 
antigen-induced antibody responses. The magnitude of the antigen-induced, antigen- 
specific response was the same, regardless of the culture vessel  (Fig.  7). In contrast, 
total IgM plus total IgO production was substantially higher in the round-bottomed 
vessels, increasing from 350 ng/ml in the fiat-bottomed vessels to 1,600 ng/ml in the 
round-bottomed vessels. 
In  another series  of experiments,  one set  of cultures  was  optimized for specific 
antigen-induced antibody responses by culturing at  1.5  ×  l06 cells/ml in the fiat- 
bottomed vessels, and another was optimized for specific and nonspecific responses by 
culturing at 5 ×  l05 cells in the round-bottomed vessels as described above. In these 
experiments, peak specific antibody production  as well as the shapes of the dose- 
response  curves  for specific  antibody production  were  basically the same  in  both 
systems (Fig.  8).  As increasing amounts of KLH were added to the fiat-bottomed 
cultures, total IgM produced in vitro did not vary significantly. However, total IgM 
production in the round-bottomed vessels showed a steady rise as additional antigen 
was added to culture. Maximum total antigen-induced IgM production in the round- 
bottomed vessels with 5 X  105 cells/culture was similar in magnitude to the amount 
of total IgM antibody generated by PWM and occurred at in vitro concentrations of 
KLH comparable with those that resulted in a peak blastogenic response (see below). 
Thus, fiat-bottomed cultures with 1.5 x  106 cells/well yielded predominantly specific 
antibody responses, whereas cultures of 5 ×  l05 cells performed in the round-bottomed 
vessels resulted in both specific antibody and polyclonal Ig production. 1052  IN  VITRO  ANTIGEN-SPECIFIC ANTIBODY  PRODUCTION  IN  MAN 
Further evidence of the selective expression of antigen-specific responses at higher 
cell numbers in flat-bottomed vessels was seen in the study of individuals boosted to 
both  KLH  and  TT.  In  cultures  performed with  5  ×  105 cells  in  round-bottomed 
vessels,  either KLH or TT at low concentrations triggered the production of specific 
antibodies directed against  both KLH and TT (Fig. 9 A). Higher concentrations of 
antigen, although they suppressed the response to the antigen in culture, continued to 
induce production of antibodies directed against the other, non-cross-reacting antigen 
to which the individual had been immunized, as part of a larger polyclonal response. 
Thus, the induction of antibody production by an antigen to which the subject had 
been recently boosted resulted in a  polyclonal response, provided the cultures were 
carried out  in  round-bottomed culture vessels  and  was  therefore nonspecific under 
that  set  of conditions.  In contrast, the suppression seen in  these same cultures was 
specific  and  involved  only  the  response  to  the  antigen  in  culture.  Neither  these 
nonspecific responses at low concentrations of antigen nor the polyclonal activation 
at  high  concentrations of antigen  were seen  in  the cultures performed in  the  flat- 
bottomed  vessels  with  1.5  ×  106  cells/well  (Fig.  9 B).  The  responses  of cultures 
performed in  this  manner  were exquisitely specific for the  stimulating  antigen  in 
terms of both induction and suppression of antibody responses. 
Relationship of Blastogenic Responses to Antibody Production.  The in vitro concentrations 
of KLH that  gave rise to peak specific antibody production  (50-200  ng/ml)  were 
several orders of magnitude less than those that caused peak blastogenesis, and those 
concentrations  of KLH  that  gave  peak  blastogenic  responses  were  suppressive  of 
specific antibody production (Fig.  10).  In addition, those concentrations of antigen 
that  did result in significant blastogenesis were the same as those that  gave rise to 
peak nonspecific, polyclonal Ig production when cultures were performed in round- 
bottomed vessels with 5 ×  105 cells (Fig. 8). It is of note that the peak specific antibody 
responses induced by antigen alone, as well as the peak blastogenic responses inducible 
by antigen alone were comparable in magnitude with those induced by PWM. 
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FIG.  10.  Re•ati•nship•fantigen•induced•antigen•speci•cantib•dypr•ducti•nt•antigen•induced 
lymphocyte blast transformation. Cultures for supernate Ig production were done in round-bottomed 
vessels with 5  ×  10  5 cells/l  ml culture and performed at  the same time as the cultures for blast 
transformation. Responses to PWM are shown as a point of reference. The data from six separate 
individuals were pooled and expressed as geometric mean +X SEM. Q, I, counts per minute; O, k~, 
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FIG.  11.  T  cell dependence of antigen-induced, antigen-specific antibody production. Results of 
triplicate cultures from two subjects  were normalized to percent maximal responses and pooled. 
Absolute values for  the  individual  peak  responses were 49  and  123  DTM/ml. Cultures were 
performed in round-bottomed vessels with 5 X 105 cells and 200 ng KLH/1 ml culture. Similar 
results have been obtained in flat-bottomed vessels  with 1.5 × 106 cells/culture. Results are expressed 
as arithmetic means +X SEM. 
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FIG. 12.  Monocyte  dependence of antigen-induced, antigen-specific  antibody production. Cultures 
5  were performed in flat-bottomed vessels  with 200 ng KLH, 7.5 X 10  monocyte-depleted  cells, and/ 
or 1.5 ×  10  ~  monocytes/1 ml culture. Results of triplicate cultures are expressed as geometric means 
+X SEM. 
Cellular Requirements. The induction of in vitro, specific anti-KLH antibody produc- 
tion by antigen was  shown to  be T  cell dependent (Fig.  11).  10%  monocytes were 
added to the T  cell populations to control for monocyte dependence. Neither B cells 
plus monocytes nor T  cells plus monocytes were capable of being triggered by antigen 
alone to  produce specific antibody. However,  the combination of the  two  in a  1:1 
ratio gave a  response comparable with that of unfractionated cells. 
The system  was  also shown  to  be  monocyte dependent  (Fig.  12).  However,  this 
phenomenon could only be demonstrated in flat-bottomed plates at low cell densities, 
most  likely as  a  result  of the  presence  of a  few  contaminating monocytes in  the 1054  IN  VITRO  ANTIGEN-SPECIFIC  ANTIBODY  PRODUCTION  IN  MAN 
monocyte-depleted preparations. Addition of >40% monocytes to culture decreased 
specific antibody production, representing either a  suppressive  influence and/or a 
diluting out of the lymphoid cells (data not shown). 
Discussion 
In the present study we have clearly demonstrated that in subjects that have been 
immunized to the soluble protein antigens KLH and/or TT, it is possible to induce 
with in vitro antigen alone a  highly specific in vitro antibody response. The system 
was shown to be T  cell- and monocyte-dependent, and the major variables affecting 
the specificity and the magnitude of the responses were antigen concentration, culture 
vessel geometry, and cell density. 
The inability to examine easily antigen-induced, antigen-specific antibody produc- 
tion in man has been one of the major impediments in the study of human B cell 
function.  In  the  present  study,  we  have  characterized  a  system  that  should  be 
particularly useful in this regard. It employs soluble protein antigens that can be used 
for in vivo immunization and that can be haptenated for in vitro studies of carrier- 
hapten relationships. We have characterized the kinetics of the circulating, antigen- 
reactive B cell repertoire after immunization as well as the in vitro kinetics of specific 
antibody production, thus allowing for more predictable responses in vitro. 
The induction of specific antibody production was not seen at the high concentra- 
tions of antigen  that  resulted  in  a  maximal blastogenic response.  However,  these 
concentrations of antigen did result in substantial total Ig production when cultures 
were performed in round-bottomed vessels  at lower cell number, which suggests a 
nonspecific induction, perhaps via recruitment or transstimulation. These findings are 
similar to those in the murine system, where it has been noted that T  cells activated 
by high concentrations of antigen may provide nonspecific help (14,  15). 
It is extremely important  to reemphasize the fact that  the use of extremely low 
concentrations of in vitro antigen has been the major factor in our ability to achieve 
high levels of specific in vitro antibody production in response to antigen alone. The 
relationship between blastogenesis and specific antibody production (Fig.  10) clearly 
demonstrates that  the concentrations  of antigen yielding a  substantial  blastogenic 
response  (those concentrations that we and others have used for years in trying to 
induce antigen-specific antibody production  in  vitro  [1,  2]),  are  several  orders  of 
magnitude beyond the optimal range. In fact, high concentrations of in vitro antigen, 
although  they  are  able  to  induce  large  amounts  of total  Ig  production  under 
appropriate culture conditions (round-bottomed culture vessel, 5 ×  l0  s cells in 1 ml), 
do so without the induction of antibody directed against the antigen in culture. 
The critical importance of cell density and culture vessel geometry in influencing 
in vitro responses is apparent in this system. Conditions that favor a  PWM response 
or a polyclonal response to antigen alone (round-bottomed vessels, low cell number) 
differ significantly from those favoring a  highly specific response  to antigen alone 
(flat-bottomed vessels, higher cell number). Whereas the absolute number of cells is 
lower in the cultures performed in the round-bottomed vessels, in fact the actual cell 
density is likely to be higher because of the geometric differences between the two 
culture  vessels.  The  greater  PWM-induced  responses,  as  well  as  the  polyclOnal 
activation observed only in the round-bottomed vessels, may be explained by the need 
for enhanced cell to cell contact for the generation of nonspecific helper factors (16) H.  C.  LANE,  D. J. VOLKMAN, G.  WHALEN,  AND A.  S.  FAUCI  1055 
and the ability of such factors to bypass the need for linked recognition (17).  The 
need for a  higher absolute number of cells in the flat-bottomed cultures to obtain a 
maximal  antigen-induced  response  probably  reflects  the  frequency  of  the  truly 
antigen-specific precursors at both the T  and B cell levels and the need for linked 
recognition (18) to induce specific antibody production under these conditions. The 
loss of either PWM or antigen-induced specific antibody production at higher cell 
densities in the flat-bottomed cultures is analogous to other studies showing that help 
and suppression may be selected for by altering the concentration of cells (19).  The 
fact that  these changes are seen at  distinctly different cell densities for PWM  and 
antigen  reinforces  the  concept  that  specific antibody production  is  occurring  via 
different mechanisms for these two stimuli. 
The dynamic state of the circulating cell repertoire involved in antibody production 
is exemplified by the changes in isotype expression seen after PWM stimulation in 
subjects studied 2 wk and then again  1 yr after booster immunization. The switch, 
with time, from an IgM to an IgG subclass of specific antibody is not observed in 
vivo, where IgM remains the predominant serologic anti-KLH isotype (20). Whether 
these changes in isotype expression are mediated at the T or B cell level remains to be 
determined. This same phenomenon appears to be true for in vitro antigen-induced, 
antigen-specific antibody production because the specific responses to a new antigen 
such as KLH are predominantly IgM, whereas those to TT, or to KLH  1 yr after 
booster immunization, are predominantly IgG. 
The precise mechanism of the specific suppression seen at the high concentrations 
of antigen  is  currently  under  study.  This  suppression  is  refractory  to  low-dose 
irradiation of the T  cells or treatment with the commercially available hybridoma 
antibodies directed against suppressor cells (H. C. Lane, D. J. Volkman, and A. S. 
Fauci, unpublished observations), suggesting that the suppression seen is not because 
of T  cells alone and may, at least in part, be a result of the direct induction of B cell 
tolerance.  This  lack of induction of T  cell  suppression  by high concentrations of 
antigen is consistent with the findings of Augustin et al. (14) and Julius and Augustin 
(15) that primed murine T  cells induced with high concentrations of antigen do not 
suppress in an antibody-forming cell assay, but in fact may provide specific as well as 
nonspecifie help. 
Systems such as this, with its ability to dissect specific and nonspecific antigen- 
induced lymphocyte responses, should prove to be of great value in furthering our 
understanding of the physiology of human B cell activation and immunoregulation 
in normal as well as diseased states. 
Summary 
A  highly specific and reproducible antigen-induced, antigen-specific culture and 
assay system for antibody production by human peripheral blood B lymphocytes has 
been  developed.  The  system  is  clearly  T  cell  and  monocyte  dependent  and  is 
independent of exogenous mitogens. The major' factors in our ability to trigger specific 
antibody production with antigen alone have been the use of extremely low concen- 
trations of antigen in vitro (doses several orders of magnitude below those inducing a 
peak blastogenic response), careful attention to in vitro cell density and culture vessel 
geometry, and appreciation of the kinetics of the circulating antigen-inducible B cell 
repertoire. 1056  IN VITRO ANTIGEN-SPECIFIC ANTIBODY PRODUCTION  IN MAN 
A  dichotomy and overlap between antigen-induced,  antigen-specific and antigen- 
induced,  polyclonal  responses  was  observed  in  the  study  of  doubly  immunized 
individuals.  Whereas  antibody responses  highly  specific  for the  antigen  in  culture 
were observed under one set of culture conditions  (flat-bottomed vessels,  1.5  ×  10  n 
cells),  switching  to  another  culture  system  (round-bottomed  vessels, 5  ×  10  5 cells) 
resulted  in  polyclonal  responses  to antigen.  Despite these culture  condition-related 
differences in the induction of antibody synthesis, the suppression of specific antibody 
production that occurred at high concentrations of antigen was specific only for the 
antigen in culture. 
The capability to easily and reproducibly look at truly antigen-induced,  antigen- 
specific antibody production should be a major tool in furthering the understanding 
of human B cell activation and immunoregulation. 
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